The First Take Podcast: Witty's departure from GlaxoSmithKline confirmed - what's his legacy?

FirstWord Pharma editors Matt Dennis and Simon King discuss Andrew Witty's time as CEO of GlaxoSmithKline, following confirmation he will retire in 2017.


To read more The First Take articles, click here.

Reference Articles